17 July 2018
: Case report
Possible Drug-nutraceutical Interaction leading to Unexpected Sequelae after Inguinal Hernia Repair
Unexpected drug reaction
Matthew R. Smith1DEF, Carl Faingold2DEF, John D. Mellinger1DEFDOI: 10.12659/AJCR.908117
Am J Case Rep 2018; 19:836-838
Abstract
BACKGROUND: Nutraceutical formulations are an area in which physicians should be increasingly aware of their side effects. This case study shows the adverse effects that ginkgo biloba can have when combined with tadalafil following an inguinal hernia repair.
CASE REPORT: A 74-year-old male presented for repair of a recurrent inguinal hernia and for which the procedure was performed without complication. Upon follow-up, it was noted that he had significant ecchymosis not only in the inguinal region but in the ventral aspect of his penis. Upon further questioning, he reported that he had been taking ginkgo biloba that was stopped 5 days prior to the operation and restarted postoperative day 1. This, combined with tadalafil, was thought to be the reason for the unexpected induration and ecchymosis at the shaft of the penis. After discontinuing both medications, the ecchymosis and induration did resolve.
CONCLUSIONS: While ecchymosis and induration are expected in the inguinal region, the appearance of significant ecchymosis and induration down the shaft of the penis was unexpected in this case, and therefore we thought it could be due to nutraceutical use of ginkgo biloba combined with tadalafil, which were started postoperatively.
Keywords: Dietary Supplements, Ginkgo biloba, Hernia, Inguinal
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947597
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.948156
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.948795
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947300
Most Viewed Current Articles
21 Jun 2024 : Case report
100,609
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
53,868
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
36,615
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
07 Jul 2023 : Case report
25,134
DOI :10.12659/AJCR.940200
Am J Case Rep 2023; 24:e940200